CompletedNCT00554177
Mifepristone or placebo to prevent emotional symptoms after sexual assault
About this title
A Clinical Trial for Post Traumatic Stress Disorder
Read the official source — NCT00554177Medication studyAges 18–65United StatesPTSD
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateSeptember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 5
- Sponsor
- Antonia New
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00554177
- Official title
Show the full official title
Mifepristone After Trauma to Enhance Resilience
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Antonia New.
Did this study involve medication?
Yes. The study involved medication, including Medicane (mifepristone) and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
